Explore the Category
When it comes to medical aid, affordability is usually the biggest consideration. However, monthly premiums should be weighed and balanced against the actual benefits and healthcare coverage being offered in order to make an informed decision.
The Council for Medical Schemes (CMS), regulator of the medical scheme industry, would like to warn the public to act with caution when dealing with Lungile Precious Myeza (Ms Myeza). Ms Myeza is not accredited in terms of the Medical Schemes Act, No. 131 of 1998 (MSA) to render broker services as a healthcare broker.
• 2019 contribution increases designed to ensure access to cover and sustainability for members • Significantly enhanced benefits for members affected by chronic conditions and cancer • Digital innovation to help members navigate the healthcare system and manage their health better
In a first for the medical scheme industry, Fedhealth has announced its 2019 benefit options which features a revolutionary new approach to benefits that gives consumers more flexibility, choice and control.
The strongest deterrent against FSP compliance missteps is or should be: